Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Equities on the Move - Research on XBiotech, Carbonite, Cellular Biomedicine and Hawaiian Telcom

NEW YORK, NY / ACCESSWIRE / November 27, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: XBiotech Inc. (NASDAQ: XBIT), Carbonite Inc. (NASDAQ: CARB), Cellular Biomedicine Group Inc. (NASDAQ: CBMG) and Hawaiian Telcom Holdco Inc. (NASDAQ: HCOM). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

XBIT Research Package: http://www.traders-choice.com/pdf?s=XBIT

CARB Research Package: http://www.traders-choice.com/pdf?s=CARB

CBMG Research Package: http://www.traders-choice.com/pdf?s=CBMG

HCOM Research Package: http://www.traders-choice.com/pdf?s=HCOM

============

Highlights from today's reports include:

On Wednesday, November 25, 2015, the NASDAQ Composite ended at 5,116.14, up 0.26%, the Dow Jones Industrial Average edged 0.01% higher to finish the day at 17,813.39, and the S&P 500 closed at 2,088.87, down 0.01%.

  • XBiotech Inc.'s stock slipped by 1.83% to close Wednesday's session at USD 8.59. The company's shares oscillated between USD 8.32 and USD 9.00 in trade during the day. The stock recorded a trading volume of 0.44 million shares, which was above its 50-day daily average volume of 0.08 million shares and above its 52-week average volume of 0.14 million shares. Over the last five days, XBiotech Inc.'s shares have declined by 35.94% and in the past one month, it has lost 40.68%. In addition, over the last three months, the stock has lost 50.12%. The shares of the company have seen some pressure and are trading below their 20-day and 50-day simple moving average by 37.33% and 42.19%, respectively. Further the stock trades at a price to book ratio of 2.41 and has a Relative Strength Index of 16.89.

  • Carbonite Inc.'s stock advanced 1.34% to close Wednesday's session at USD 9.85. The share price vacillated between USD 9.75 and USD 9.90 during the day. The stock recorded a trading volume of 0.05 million shares, which was below its 50-day daily average volume of 0.09 million shares and below its 52-week average volume of 0.15 million shares. Over the last three days Carbonite Inc.'s shares have declined by 1.50% while in the past one week it has moved up 1.76%. Moreover, in the last six months, the stock has lost 10.37% and year to date, the shares have shed 30.97%. The shares of the company are trading below their 20-day and 50-day simple moving average by 3.08% and 8.77% respectively. Additionally, the stock is trading at a price to cash flow ratio of 331.96 and at a price to sales ratio of 1.98.

  • Cellular Biomedicine Group Inc.'s stock edged higher by 1.29% to close Wednesday's session at USD 22.85. The company’s shares oscillated between USD 22.15 and USD 23.23 in trade during the day. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.06 million shares and below its 52-week average volume of 0.08 million shares. Over the last three days, Cellular Biomedicine Group Inc.'s shares have advanced 10.23% and in the past one week it has moved up 0.62%. Furthermore, over the last three months, the stock has gained 0.88% whereas in the past six months, the shares have shed 42.01%. The shares of the company are trading above their 20-day and 50-day simple moving averages by 0.89% and 12.58%, respectively. However, they are trading below their 200-day simple moving average by 18.57%.

  • The stock of Hawaiian Telcom Holdco Inc. lost 0.39% to close Wednesday's session at USD 22.97. The shares of the company moved in the range of USD 22.48 and USD 23.08 during the day. A trading volume of 0.029 million shares was recorded, which was lower than its 150-day daily average volume and its 52-week average volume of 0.03 million shares each. Over the last five days, Hawaiian Telcom Holdco Inc.'s shares have remained flat while in the past one month, the stock has lost 4.57%. Additionally, over the last three months, the stock has advanced 4.41% whereas in the past six months, the shares have registered a loss of 9.92%. Further, the company is trading at a price to earnings ratio of 69.61 which compares to a historical PE ratio of 38.49. Hawaiian Telcom Holdco Inc.' shares are having a market cap of USD 263.38 million.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today